Did They Pay?

Category: Follow the Money

Original analysis and explainers about insurer finances, reimbursement trends, claim-denial data, appeal outcomes, healthcare costs, payment practices, and public reporting.

  • How Can You Tell Whether an Insurer’s Denial Rate Actually Means Anything?

    An insurer’s denial rate is useful only when the numerator, denominator, time period, product, and type of denial are clear. A statistic about prior authorization requests cannot be compared directly with one about paid medical claims. Before drawing conclusions, ask what counted as a denial, whether repeat submissions were counted, and how many decisions were appealed or reversed.

    What exactly is being denied?

    Health insurance produces several different decisions: a prior authorization for future treatment, a pharmacy benefit request, a submitted claim, a line item within a claim, or a post-payment audit. A payer can reject an electronic claim before adjudication because required information is missing; that is not necessarily a medical-necessity denial. A single hospital claim can also contain many service lines. Counting claims, lines, requests, or patients yields different rates. Good analysis states the unit of measurement.

    Why the denominator changes the story

    Suppose two hypothetical insurers each deny 100 requests. If the first receives 1,000 requests, its measured denial share is 10%; if the second receives 10,000, it is 1%. Those arithmetic examples do not prove either insurer treats patients better. Differences in patient populations, service types, authorization requirements, coding quality, network design, and claims-processing rules can distort comparisons. The best denominator is the population of comparable decisions, not an unrelated enrollment figure or dollar amount.

    How to read an appeal reversal statistic

    An appeal reversal rate often uses only the denials that someone actually appealed. If relatively few denials are appealed, a high reversal percentage does not mean most original denials were overturned. Imagine 1,000 denials, 50 appeals, and 30 reversals: 60% of appealed denials were reversed, but 30 of the original 1,000 denials were overturned through those recorded appeals. That gap raises important questions about patient knowledge, burden, and access to review; it does not alone establish whether each unappealed decision was correct.

    Separate payment delays from outright denials

    Providers should also measure days in accounts receivable, first-pass acceptance, clean-claim payment time, underpayments against contracted rates, recoupments, and the share of denials eventually resolved. An insurer that pays late but rarely issues formal denials may still create serious financial harm. A useful provider dashboard groups cases by payer, product, service, date received, denial reason, initial payment, final payment, and appeal outcome. Keep adjustments distinct from cash received.

    What data should journalists and advocates request?

    Ask for the methodology, time window, sample size, plan type, geographic scope, exclusions, and definitions. Request separate counts for submitted requests, approved requests, denied requests, appealed denials, upheld decisions, reversals, and cases with no final disposition. Look for whether decisions were made by the payer or delegated vendor. If comparing insurers, specify how case mix was addressed. The absence of these details is a reason for caution, not permission to fill in a more dramatic conclusion.

    How can a patient use data without losing sight of their case?

    Population statistics may support a question about patterns, but a particular appeal needs the actual notice, coverage language, medical evidence, and timeline. Our evidence-based appeal guide explains how to address the stated reason for an individual decision. A patient should ask whether a denial was procedural, contractual, or clinical, and which route can change it. A physician’s documentation can be decisive for clinical criteria; it cannot by itself rewrite a coverage exclusion.

    How should public figures be described responsibly?

    Use precise labels such as “share of prior authorization requests denied in this dataset” rather than “share of care denied to patients.” Say whether a reversal rate is among appealed cases. Avoid inferring illegal conduct from a high denial percentage alone. Compare documented practices against governing rules and actual notices. Investigative accountability becomes stronger when the claim is narrow enough to test.

    Frequently asked questions

    Does a low denial rate prove a good insurer? No; access, benefit design, payment timeliness, and service mix also matter.
    Are overturned denials automatically unlawful? No; reversals can follow new information or a different review.
    Can providers publish their own data? They can analyze de-identified operational trends, but must protect patient information and explain selection bias.

    Research starting points

    Review CMS’s prior authorization reporting framework for the types of metrics certain payers must disclose, and CMS’s explanation of Medicare Advantage organization determinations to distinguish decisions. For private-plan appeals, HealthCare.gov explains available review routes.

  • Who Benefits Financially When an Insurance Claim Is Delayed?

    Who Benefits Financially When an Insurance Claim Is Delayed The practical answer is to identify the exact rule or claim status, gather contemporaneous evidence, request a written explanation, and use the review pathway that applies to the specific plan. Patients and medical practices should keep a dated record of every handoff, because a documented sequence is more useful than repeated phone calls without reference numbers.

    A delay is not proof of deliberate misconduct

    An insurer’s payment delay can temporarily preserve cash, but it may also create administrative expense, contractual interest obligations, regulatory exposure and provider dissatisfaction. It is not sound to infer profit or bad faith from one unresolved claim. The accountability question is whether the payer processed the claim according to its rules, contract and applicable law.

    Follow the money through the entire claim

    A patient may face collection notices, an uncertain balance or postponed treatment. A practice may carry payroll and overhead while waiting for reimbursement. A hospital may borrow or use reserves. The insurer or administrator may retain funds during processing, but ultimate financial benefit depends on the arrangement, including whether the organization is an insurer taking risk or a third-party administrator paid a fee.

    Identify the plan and the payer’s role

    Fully insured commercial plans, self-funded employer plans, Medicare Advantage, original Medicare contractors and Medicaid managed care operate under different legal and payment arrangements. The logo on a card does not necessarily identify who bears the claim cost. Ask whether the entity is the insurer, claims administrator, network, clearinghouse or pharmacy benefit manager.

    Measure delays rather than speculate about motives

    For a practice, track clean-claim submission date, acceptance acknowledgement, requests for information, adjudication date, remittance date and payment deposit. Separate rejections from denials and underpayments. Compare like-for-like claims and account for coding corrections, missing records and coordination of benefits.

    Look for contractually meaningful patterns

    Check timely-payment clauses, prompt-pay requirements, interest provisions, appeal procedures and any exceptions for incomplete claims. State prompt-pay statutes may not govern self-funded ERISA plans or federal programs in the same way. A provider’s contract may impose separate deadlines. Obtain the actual governing document before alleging a violation.

    Document the cost without exaggeration

    A practice can estimate staff hours spent on each follow-up and distinguish that cost from interest, borrowing expense and uncollectible balances. Patients can document actual late fees, missed appointments and out-of-pocket expenses, while avoiding unsupported assumptions about medical causation.

    Escalate with evidence

    Send a written claim chronology identifying claim numbers, dates, acceptance receipts, requested records and the specific payment or explanation sought. Ask for the legal or contractual basis for further delay. If unresolved, use the plan’s appeal or provider dispute process and the appropriate regulator or contract remedy.

    Further reading and official guidance

    For a related practical discussion, see this Did They Pay? accountability guide. For official information, consult CMS medical billing rights resources. Rules and deadlines depend on the coverage arrangement; check the current plan documents.

    Frequently asked questions

    Do insurers always earn money by delaying claims?

    No. Cash-flow effects are possible, but administrative costs, interest, penalties and contractual arrangements change the economics.

    Can a provider charge the patient while a claim is pending?

    That depends on the provider agreement, plan terms and applicable billing protections. Patients should request an itemized bill and ask that disputed balances be reviewed.

  • Does a Health Insurer’s Medical Loss Ratio Show Whether It Pays Claims Fairly?

    A medical loss ratio shows how much qualifying premium revenue an insurer devotes to medical care and quality improvement under a defined reporting method. It does not reveal whether a particular claim was correctly denied, whether providers were paid promptly, or whether patients obtained timely care. To evaluate fairness, pair financial disclosures with claims decisions, appeals, payment timing, and documented patient outcomes.

    What the ratio measures

    The Affordable Care Act’s medical loss ratio rules generally require covered insurers to devote at least 80 percent or 85 percent of adjusted premium revenue to qualifying care and quality improvement, depending on the market. Insurers that fall below the applicable threshold may owe rebates under the program’s calculation rules. This is a financial accountability measure, not an approval rate. It should not be read as a promise that every claim will be paid or every medical service covered.

    Why a high number can coexist with disputed denials

    Imagine two insurers with similar ratios. One may communicate decisions clearly and pay valid claims promptly; the other may generate repeated requests for records and overturn substantial numbers of initial denials on appeal. Aggregate spending alone cannot distinguish those experiences. A high ratio can reflect high medical costs, pricing, enrollment mix, or other factors rather than excellent administration. Conversely, a lower figure does not independently establish illegal denial practices.

    Check the correct insurer, market and year

    CMS publishes medical loss ratio resources and reporting data. Before comparing companies, identify the legal insurance issuer rather than only the brand on the membership card. Confirm the state, individual or group market, and reporting year. A parent company may operate several issuers and markets. A national corporate figure may not describe the plan that handled a patient’s claim. Do not mix medical loss ratios with a hospital’s operating margin or with malpractice liability insurance payouts: these are different financial measures.

    What additional evidence is necessary

    A meaningful accountability assessment asks how many claims were submitted, denied initially, appealed, overturned, and paid after reconsideration. The definitions of a claim and a denial matter. For example, a rejected electronic transaction before adjudication may be excluded from a published denial statistic. Timeliness measures should distinguish ordinary processing from corrected claims and appeals. Patient access also requires separate evidence about provider networks, authorization delays, and actual treatment availability.

    Follow the financial incentives without assuming misconduct

    Delaying a payment may affect cash flow, but that observation alone does not prove an insurer deliberately delayed claims for profit. To investigate a specific pattern, collect remittance records, denial codes, dates, plan terms, and written correspondence. Compare similarly situated claims before alleging a systematic practice. A payer may have legitimate documentation or eligibility questions; it must still explain its decision under the applicable rules. Ask who bears administrative costs while a dispute continues: patients, clinicians, hospitals, and sometimes public programs.

    A practical comparison checklist

    When evaluating an insurer, record the issuer name, market, year, reported medical loss ratio, available denial and appeal metrics, and the source of each figure. Label unavailable metrics as unavailable, not zero. Compare like with like. If a plan cites a high medical loss ratio as proof of good performance, ask for separate measures of timely payment, appeals, and access. The question is not merely how much money ultimately went toward care, but whether legitimate requests were handled fairly along the way.

    Further reading and official guidance

    See our related guide: practical background and next steps. For applicable official guidance, consult the federal source on this topic. Rules and deadlines depend on the plan and circumstances.